Stage: Research

908 Devices makes handheld and desktop mass spectrometry devices to enable lab analysis wherever and whenever it’s needed.

Ansa Biotechnologies is building a next-generation, enzyme-based approach to DNA synthesis that accelerates synthetic biology research.

DNAnexus is a secure cloud platform and global network for scientific collaboration to support accelerating discoveries in genomic, multiomic, and precision medicine.

Elephas is a live tumor imaging company developing novel cancer diagnostic solutions to predict treatment outcomes and accelerate drug development.

Emulate is pioneering organ-on-a-chip technology and enabling laboratory simulation of the human response to medicines, chemicals, and foods.

Encodia enables researchers to probe the immense complexities of the proteome routinely at a scale and resolution that was previously unattainable.

EnPlusOne is manufacturing the RNA medicines of the future.

Isolation Bio enables access to the living microbiome at unprecedented scale, enabling scientists to uncover deeper insights.

Molecule’s marketplace and ecosystem leverages web3 technology to increase access to funding and commercialization opportunities for biotech research.

NanoView characterizes exosomes – which are how cells communicate with each other – direct from sample and without purification.

OPT combines computational design, automation engineering, and material science to algorithmically design and digitally manufacture superior materials.

PhenomeX is empowering scientists to leverage the full potential of each cell and drive the next era of functional cell biology that will advance human health.

QbDVision is helping to digitize biopharma manufacturing with a cloud-based workspace that aims to consolidate workflow and knowledge management.

Refeyn is a research tools company whose novel technology can find and characterize single molecules in only one minute, rapidly accelerating research for new drugs.

Scitara provides laboratory-specific, cloud-based software solutions to enable scientific labs with modern lab data connectivity infrastructure and tools.

Slingshot Biosciences develops synthetic cells for a range of applications in diagnostics and therapeutics.

Telesis bridges the digital and biological words to create specific genetic components that researchers need to better understand diseases and develop therapies.

Ultivue’s immunohistochemistry platform is used in cancer research by leading biopharmaceutical companies to provide sensitive and comprehensive biomarker information that can advance promising cancer drugs to and through clinical trials.

Vizgenā€™s multiplexed FISH technology, “MERFISH” allows researchers to profile gene expression with sub-cellular spatial resolution.